About GlyTech
GlyTech is a company based in Kyoto (Japan) founded in 2012. GlyTech has raised $9.14 million across 2 funding rounds from investors including Yokogawa, Osaka University and Nippon Shokubai. GlyTech operates in a competitive market with competitors including Echelon Biosciences, Iceni Glycoscience, GlycoSpot, TFChem and ADDAX Biosciences, among others.
- Headquarter Kyoto, Japan
- SectorsHealthcare
- Phone•••• ••••
- Website glytech-inc.com
- Social LinkedIn X
- Total Equity Funding$9.14M (USD)
in 2 rounds
- InvestorsYokogawa
& 5 more
Funding Insights of GlyTech
GlyTech has successfully raised a total of $9.14M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.14M
- Total Rounds 2
- First Round $9.14M
(May 2018)
- Investors Count 6
All 2 funding rounds of GlyTech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2022 | – | Series B | – | Yokogawa | – |
| May 2018 | $9.14M | Series A | – | Nippon Shokubai, Fushimi Pharmaceutica |
6 investors in total: 6 institutional.
Investors in GlyTech
GlyTech has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Yokogawa, Osaka University and Nippon Shokubai.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital funds are managed to support unlisted companies' growth. | – | sbinvestment.co.jp | Minato City, Japan | |
Cloud-based industrial automation and process control solutions are offered. | 1915 | yokogawa.com | Tokyo, Japan | |
Chemical catalysts and absorbents are manufactured by the company. | 1941 | shokubai.co.jp | Osaka, Japan | |
Fushimi Pharmaceutical is engaged in developing and selling pharmaceuticals and chemicals. | – | fushimi.co.jp | Japan | |
University offering multiple courses and degrees across diversified streams | 1931 | osaka-u.ac.jp | Osaka, Japan | |
Miat is engaged in trading pharmaceutical and nutraceutical products. | – | miat.it | Milan, Italy |
Investor details for GlyTech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GlyTech
1 people are tracked at GlyTech (1 in leadership).
| Name | Role | Group |
|---|---|---|
Hiroaki Asai | CEO | Leadership |
Complete people profiles for GlyTech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GlyTech
3 dated milestones of GlyTech across 10 years, from founding to its latest funding, stage changes and deals.
- Founded GlyTech is founded.
- Funding First funding round of $9.1M.
- Funding Latest funding round, Series B,.
Competitors of GlyTech
GlyTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Echelon Biosciences, Iceni Glycoscience, GlycoSpot, TFChem and ADDAX Biosciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| echelon-inc.com | 1997 | Salt Lake, United States | – | – | Reagents and assays for lipid biology research are manufactured. | |
| iceniglycoscience.com | 2014 | Norwich, United Kingdom | $1.77M | 16 | Glycoscience platform is provided for diagnostic and therapeutic applications. | |
| glycospot.dk | 2014 | Frederiksberg, Denmark | $3.58M | 13 | High-throughput enzyme screening solutions are developed and provided. | |
| tfchemistry.com | 2007 | Rouen, France | – | – | Fluoride chemistry is utilized to design glycomimetic drug compounds. | |
| addaxbio.com | 2017 | Turin, Italy | – | – | Developer of a non-toxic formalin alternative tissue fixative. This fixative provides comparable or superior results to formalin in histological, immunohistochemical, and molecular analyses, while eliminating the carcinogenic and toxic risks associated with formalin use. The product is protected by an international patent and is designed for use in histology laboratories, improving both patient care and worker safety. The company collaborates with various research institutions to advance the application of this technology in different fields. | |
| avantilipids.com | 1969 | Alabaster, United States | – | 134 | Phospholipids and lipids are manufactured for life science applications. | |
| elicityl-oligotech.com | 2002 | Crolles, France | $136,856 | – | Oligo and polysaccharides are supplied for agriculture and other sectors. |
Detailed competitors of GlyTech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GlyTech
The website of GlyTech (glytech-inc.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▼ 29.2% vs previous month
Latest news on Glytech
Complete news archive for GlyTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to GlyTech
10 companies that operate in the same segment as GlyTech (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GlyTech
GlyTech was founded in 2012 and raised its 1st funding round 6 years after it was founded.
GlyTech is headquartered in Kyoto, Japan. It is registered at Kyoto, Kyoto Prefecture, Japan.
Hiroaki Asai is the current CEO of GlyTech.
GlyTech is a funded company, having raised a total of $9.14M across 2 funding rounds to date. The company's 1st funding round was a Series A of $9.14M, raised on May 2018.
GlyTech was established in 2012 in Kyoto, Japan, within the biotechnology sector. Human-type asparagine-linked glycans are provided for research purposes. Operations center on glycan production and chemical glycosylation technologies, which are applied to medicine development, including biopharmaceuticals and oligonucleotide therapeutics. The companys activities support advancements in these therapeutic areas through specialized glycan solutions.
GlyTech's top competitors include Echelon Biosciences, Iceni Glycoscience and GlycoSpot.
GlyTech has 6 investors. Key investors include Yokogawa, Osaka University, Nippon Shokubai, Fushimi Pharmaceutical, and Miat.